OS Therapies
PublicOS Therapies is now publicly traded
The data on this page reflects OS Therapies's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Convertible Debt
Jul 16, 2026
Total Funding Raised
$3.6M
Company Overview
OS Therapies is a clinical-stage biopharmaceutical company that focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors.
AI Layer
Non-AI
Keywords
immunotherapyosteosarcomabiopharmaceuticalcancer vaccineListeria-based immunotherapysolid tumor treatmentclinical-stage biotechoncology researchbone cancer treatmentclinical trialsdrug developmentbiotech startuporphan drug
OS Therapies Comparables
Compare OS Therapies with similar companies based on industry and business-model similarity.
OS Therapies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Jul 16, 2026 | ||||
| Seed Round | Mar 6, 2026 |
Key People
Founding team and executive leadership
OS Therapies Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Firmographic Details
Headquarters—
Employee Range11
Year Founded2018
Last FundingJul 16, 2026